Latest Breaking News On - Artivion inc - Page 16 : comparemela.com

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results

ATLANTA, Oct. 19, 2023 /PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2023 financial results will

United statesD ashley leePat mackinBrian johnston lynn lewisGilmartin groupPrnewswire artivion incArtivion incChief executive officer

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results

/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2023.

United statesBrian johnston lynn lewisPat mackinD ashley leePrnewswire artivion incArtivion incGilmartin groupChief executive officerLynn lewisHealth care amp hospitalsMedical equipmentMedical pharmaceuticalsConference call announcements

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesBrian johnston lynn lewisPat mackinD ashley leeGilmartin groupArtivion incPrnewswire artivion incChief executive officerLynn lewis

Artivion Announces Presentation of Real World Data from Post Market Study of On-X Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin

ATLANTA - Artivion, Inc. , a leading cardiac and vascular surgery company focused on aortic disease, today announced data from its On-X Aortic Heart Valve Low INR post-market study presented in a.

City ofUnited kingdomEuropean association for cardioArtivion incOnx aortic heart valve lowLate breaking scienceCardio thoracic surgeryAnnual meetingOnx aortic valveClinical leadAortovascular surgeryBarts heart centreReal world experienceLow doseNews publishing

Artivion (AORT) Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial

Artivion (AORT) Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Fernando fleischmanPat mackinEuropean association for cardioArtivion incLate breaking scienceEuropean associationCardio thoracic surgeryAnnual meetingAssociate professorClinical surgeryKeck hospitalSouthern californiaAcute debakey typei dissectionPersevere investigational device exemption studyPost op paraplegiaChief executive officer